🇺🇸 FDA
Patent

US 7273710

Method for screening MCH receptor antagonist/agonist

granted A61KA61K38/00A61P

Quick answer

US patent 7273710 (Method for screening MCH receptor antagonist/agonist) held by Takeda Pharmaceutical Company Limited expires Mon Sep 20 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Sep 25 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 20 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K38/00, A61P, A61P5/00